$INFI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INFINITY PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INFINITY PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INFINITY PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 18 2012 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Buy | M | 8.87 | 2,500 | 22,175 | 7,500 | 5 K to 7.5 K (+50.00 %) |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | M | 5.94 | 76,930 | 456,964 | 83,620 | |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | M | 6.25 | 23,070 | 144,188 | 340,930 | |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | M | 7.18 | 13,927 | 99,996 | 0 | |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | M | 9.80 | 10,204 | 99,999 | 0 | |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | M | 13.59 | 29,432 | 399,981 | 0 | |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | M | 3.48 | 331 | 1,152 | 0 | |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | M | 3.48 | 22,103 | 76,918 | 0 | |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | M | 5.94 | 76,930 | 456,964 | 492,535 | 415.6 K to 492.5 K (+18.51 %) |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | M | 6.25 | 23,070 | 144,188 | 415,605 | 392.5 K to 415.6 K (+5.88 %) |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | M | 7.18 | 13,927 | 99,996 | 392,535 | 378.6 K to 392.5 K (+3.68 %) |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | M | 9.80 | 10,204 | 99,999 | 378,608 | 368.4 K to 378.6 K (+2.77 %) |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | M | 13.59 | 29,432 | 399,981 | 368,404 | 339 K to 368.4 K (+8.68 %) |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | M | 3.48 | 331 | 1,152 | 338,972 | 338.6 K to 339 K (+0.10 %) |
Dec 10 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | M | 3.48 | 22,103 | 76,918 | 338,641 | 316.5 K to 338.6 K (+6.98 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 6.80 | 6,000 | 40,800 | 0 | |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 6.80 | 10,000 | 68,000 | 0 | |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 6.74 | 5,625 | 37,913 | 0 | |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 6.74 | 9,375 | 63,188 | 0 | |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 5.63 | 5,625 | 31,669 | 0 | |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 5.63 | 9,375 | 52,781 | 0 | |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 7.70 | 9,375 | 72,188 | 0 | |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 9.23 | 1,407 | 12,987 | 0 | |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | M | 15.04 | 1,875 | 28,200 | 0 | |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 6.80 | 6,000 | 40,800 | 59,580 | 53.6 K to 59.6 K (+11.20 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 6.80 | 10,000 | 68,000 | 53,580 | 43.6 K to 53.6 K (+22.95 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 6.74 | 5,625 | 37,913 | 43,580 | 38 K to 43.6 K (+14.82 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 6.74 | 9,375 | 63,188 | 37,955 | 28.6 K to 38 K (+32.80 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 5.63 | 5,625 | 31,669 | 28,580 | 23 K to 28.6 K (+24.50 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 5.63 | 9,375 | 52,781 | 22,955 | 13.6 K to 23 K (+69.04 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 7.70 | 9,375 | 72,188 | 13,580 | 4.2 K to 13.6 K (+222.95 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 9.23 | 1,407 | 12,987 | 4,205 | 2.8 K to 4.2 K (+50.29 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | M | 15.04 | 1,875 | 28,200 | 2,798 | 923 to 2.8 K (+203.14 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | J | 0.00 | 923 | 0 | 923 | 0 to 923 |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Buy | J | 0.00 | 4,832 | 0 | 316,551 | 311.7 K to 316.6 K (+1.55 %) |
Nov 28 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Sell | J | 0.00 | 864,565 | 0 | 311,719 | 1.2 M to 311.7 K (-73.50 %) |
Nov 29 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Sell | S | 24.62 | 4,832 | 118,958 | 294,071 | 298.9 K to 294.1 K (-1.62 %) |
Nov 29 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Sell | S | 25.28 | 17,648 | 446,171 | 298,903 | 316.6 K to 298.9 K (-5.58 %) |
Nov 27 2012 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | See Remarks | Option Exercise | M | 9.80 | 3,885 | 38,073 | 0 | |
Nov 27 2012 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | See Remarks | Option Exercise | M | 14.33 | 10,000 | 143,300 | 10,000 | |
Nov 27 2012 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | See Remarks | Sell | S | 25.73 | 13,885 | 357,272 | 0 | 13.9 K to 0 (-100.00 %) |
Nov 27 2012 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | See Remarks | Buy | M | 9.80 | 3,885 | 38,073 | 13,885 | 10 K to 13.9 K (+38.85 %) |
Nov 27 2012 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | See Remarks | Buy | M | 14.33 | 10,000 | 143,300 | 10,000 | 0 to 10 K |
Oct 16 2012 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | M | 8.87 | 5,000 | 44,350 | 5,000 | |
Oct 16 2012 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Buy | M | 8.87 | 5,000 | 44,350 | 5,000 | 0 to 5 K |
Sep 11 2012 | INFI | INFINITY PHARMACEU ... | Rosebay Medical Co L.P. | 10% Owner | Option Exercise | H | 40.00 | 1,500,000 | 60,000,000 | 0 | |
Sep 11 2012 | INFI | INFINITY PHARMACEU ... | Rosebay Medical Co L.P. | 10% Owner | Option Exercise | H | 30.00 | 1,000,000 | 30,000,000 | 0 | |
Sep 11 2012 | INFI | INFINITY PHARMACEU ... | Rosebay Medical Co L.P. | 10% Owner | Option Exercise | H | 20.00 | 500,000 | 10,000,000 | 0 | |
Sep 11 2012 | INFI | INFINITY PHARMACEU ... | Rosebay Medical Co L.P. | 10% Owner | Buy | P | 14.50 | 5,416,565 | 78,540,193 | 5,416,565 | 0 to 5.4 M |
Sep 11 2012 | INFI | INFINITY PHARMACEU ... | Beacon Co | 10% Owner | Option Exercise | H | 40.00 | 1,500,000 | 60,000,000 | 0 | |
Sep 11 2012 | INFI | INFINITY PHARMACEU ... | Beacon Co | 10% Owner | Option Exercise | H | 30.00 | 1,000,000 | 30,000,000 | 0 | |
Sep 11 2012 | INFI | INFINITY PHARMACEU ... | Beacon Co | 10% Owner | Option Exercise | H | 20.00 | 500,000 | 10,000,000 | 0 | |
Sep 11 2012 | INFI | INFINITY PHARMACEU ... | Beacon Co | 10% Owner | Buy | P | 14.50 | 5,416,565 | 78,540,193 | 5,416,565 | 0 to 5.4 M |
Sep 06 2012 | INFI | INFINITY PHARMACEU ... | Santabarbara Pedro | Chief Medical Offic ... | Option Exercise | M | 6.50 | 9,200 | 59,800 | 150,800 | |
Sep 06 2012 | INFI | INFINITY PHARMACEU ... | Santabarbara Pedro | Chief Medical Offic ... | Buy | M | 6.50 | 9,200 | 59,800 | 9,200 | 0 to 9.2 K |
Jul 25 2012 | INFI | INFINITY PHARMACEU ... | BLOCH LAWRENCE E | EVP, CFO & CBO | Option Exercise | A | 15.85 | 200,000 | 3,170,000 | 200,000 | |
Jun 04 2012 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Director | Sell | S | 13.01 | 57,573 | 749,025 | 0 | 57.6 K to 0 (-100.00 %) |
May 31 2012 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Director | Sell | S | 13.00 | 10,958 | 142,454 | 57,573 | 68.5 K to 57.6 K (-15.99 %) |
May 31 2012 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Director | Sell | S | 13.00 | 189,303 | 2,460,939 | 68,531 | 257.8 K to 68.5 K (-73.42 %) |
May 31 2012 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Director | Gift | G | 0.00 | 15,000 | 0 | 257,834 | 272.8 K to 257.8 K (-5.50 %) |
May 18 2012 | INFI | INFINITY PHARMACEU ... | LANDER ERIC S | Director | Option Exercise | A | 12.94 | 6,000 | 77,640 | 6,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Director | Option Exercise | A | 12.94 | 12,000 | 155,280 | 12,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Director | Option Exercise | A | 12.94 | 6,000 | 77,640 | 6,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | Lee Patrick Pak-Tin | Director | Option Exercise | A | 12.94 | 6,000 | 77,640 | 6,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 12.94 | 4,000 | 51,760 | 4,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 12.94 | 6,000 | 77,640 | 6,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | Lynch Thomas J. Jr. | Director | Option Exercise | A | 12.94 | 6,000 | 77,640 | 6,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | Babler Martin | Director | Option Exercise | A | 12.94 | 2,000 | 25,880 | 2,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | Babler Martin | Director | Option Exercise | A | 12.94 | 6,000 | 77,640 | 6,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 12.94 | 6,000 | 77,640 | 6,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | Fyfe Gwen A. | Director | Option Exercise | A | 12.94 | 6,000 | 77,640 | 6,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 12.94 | 4,000 | 51,760 | 4,000 | |
May 18 2012 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 12.94 | 6,000 | 77,640 | 6,000 | |
May 17 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 12.94 | 10,000 | 129,400 | 10,000 | |
May 17 2012 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 12.94 | 6,000 | 77,640 | 6,000 | |
Mar 12 2012 | INFI | INFINITY PHARMACEU ... | SELBY NORMAN C | Director | Option Exercise | A | 8.87 | 10,000 | 88,700 | 10,000 | |
Mar 12 2012 | INFI | INFINITY PHARMACEU ... | Fyfe Gwen A. | Director | Option Exercise | A | 8.87 | 10,000 | 88,700 | 10,000 | |
Jan 09 2012 | INFI | INFINITY PHARMACEU ... | Quirk Gerald E | See Remarks | Option Exercise | A | 7.93 | 40,000 | 317,200 | 40,000 | |
Jan 09 2012 | INFI | INFINITY PHARMACEU ... | Tucker Winselow S. Jr. | VP, Marketing | Option Exercise | A | 7.93 | 30,104 | 238,725 | 30,104 | |
Jan 09 2012 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | A | 7.93 | 47,136 | 373,788 | 47,136 | |
Jan 09 2012 | INFI | INFINITY PHARMACEU ... | Hamermesh Joshua | See Remarks | Option Exercise | A | 7.93 | 11,844 | 93,923 | 11,844 | |
Jan 09 2012 | INFI | INFINITY PHARMACEU ... | Santabarbara Pedro | Chief Medical Offic ... | Option Exercise | A | 7.93 | 47,136 | 373,788 | 47,136 | |
Jan 09 2012 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | See Remarks | Option Exercise | A | 7.93 | 191,750 | 1,520,578 | 191,750 | |
Jan 09 2012 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | See Remarks | Option Exercise | A | 7.93 | 30,104 | 238,725 | 30,104 | |
Jan 09 2012 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 7.93 | 126,850 | 1,005,921 | 126,850 | |
May 20 2011 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 6.80 | 10,000 | 68,000 | 10,000 | |
May 20 2011 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 6.80 | 6,000 | 40,800 | 6,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Director | Option Exercise | A | 6.80 | 12,000 | 81,600 | 12,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Director | Option Exercise | A | 6.80 | 6,000 | 40,800 | 6,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | LANDER ERIC S | Director | Option Exercise | A | 6.80 | 6,000 | 40,800 | 6,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | Babler Martin | Director | Option Exercise | A | 6.80 | 2,000 | 13,600 | 2,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | Babler Martin | Director | Option Exercise | A | 6.80 | 6,000 | 40,800 | 6,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | Lee Patrick Pak-Tin | Director | Option Exercise | A | 6.80 | 6,000 | 40,800 | 6,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | LEVINE ARNOLD J | Director | Option Exercise | A | 6.80 | 6,000 | 40,800 | 6,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 6.80 | 4,000 | 27,200 | 4,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 6.80 | 6,000 | 40,800 | 6,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | Lynch Thomas J. Jr. | Director | Option Exercise | A | 6.80 | 6,000 | 40,800 | 6,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 6.80 | 4,000 | 27,200 | 4,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 6.80 | 6,000 | 40,800 | 6,000 | |
May 19 2011 | INFI | INFINITY PHARMACEU ... | TANANBAUM JAMES B | Director | Option Exercise | A | 6.80 | 6,000 | 40,800 | 6,000 | |
Jan 07 2011 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D | Option Exercise | A | 5.94 | 106,210 | 630,887 | 106,210 | |
Jan 07 2011 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Director | Option Exercise | A | 5.94 | 120,000 | 712,800 | 120,000 | |
Jan 07 2011 | INFI | INFINITY PHARMACEU ... | Tucker Winselow S. Jr. | Vice President, Mar ... | Option Exercise | A | 5.94 | 6,552 | 38,919 | 6,552 | |
Jan 07 2011 | INFI | INFINITY PHARMACEU ... | Quirk Gerald E | VP,Cor. Affairs & G ... | Option Exercise | A | 5.94 | 9,828 | 58,378 | 9,828 | |
Jan 07 2011 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | A | 5.94 | 160,550 | 953,667 | 160,550 | |
Jan 07 2011 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | Controller & Asst. ... | Option Exercise | A | 5.94 | 9,828 | 58,378 | 9,828 | |
Jan 07 2011 | INFI | INFINITY PHARMACEU ... | Palombella Vito J. | Chief Scientific Of ... | Option Exercise | A | 5.94 | 39,520 | 234,749 | 39,520 | |
Dec 17 2010 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | P | 6.00 | 809 | 4,854 | 316,538 | 315.7 K to 316.5 K (+0.26 %) |
Dec 17 2010 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | P | 6.12 | 10,000 | 61,150 | 315,729 | 305.7 K to 315.7 K (+3.27 %) |
Dec 17 2010 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | P | 6.10 | 14,191 | 86,565 | 305,729 | 291.5 K to 305.7 K (+4.87 %) |
Dec 13 2010 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Exec Chair of the B ... | Grant | A | 0.00 | 100,000 | 0 | 275,535 | 175.5 K to 275.5 K (+56.97 %) |
Aug 26 2010 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | P | 4.99 | 5,349 | 26,692 | 291,538 | 286.2 K to 291.5 K (+1.87 %) |
Aug 26 2010 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Buy | P | 4.89 | 44,651 | 218,343 | 286,189 | 241.5 K to 286.2 K (+18.49 %) |
Aug 02 2010 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | Controller & Asst. ... | Option Exercise | A | 6.00 | 27,000 | 162,000 | 27,000 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 6.74 | 9,375 | 63,188 | 9,375 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 6.74 | 5,625 | 37,913 | 5,625 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | Babler Martin | Director | Option Exercise | A | 6.74 | 1,875 | 12,638 | 1,875 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | Babler Martin | Director | Option Exercise | A | 6.74 | 5,625 | 37,913 | 5,625 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | Lee Patrick Pak-Tin | Director | Option Exercise | A | 6.74 | 5,625 | 37,913 | 5,625 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | LANDER ERIC S | Director | Option Exercise | A | 6.74 | 5,625 | 37,913 | 5,625 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | Lynch Thomas J. Jr. | Director | Option Exercise | A | 6.74 | 5,625 | 37,913 | 5,625 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | LEVINE ARNOLD J | Director | Option Exercise | A | 6.74 | 5,625 | 37,913 | 5,625 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | Moss Franklin | Director | Option Exercise | A | 6.74 | 5,625 | 37,913 | 5,625 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 6.74 | 3,750 | 25,275 | 3,750 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 6.74 | 5,625 | 37,913 | 5,625 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | TANANBAUM JAMES B | Director | Option Exercise | A | 6.74 | 5,625 | 37,913 | 5,625 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 6.74 | 3,750 | 25,275 | 3,750 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 6.74 | 5,625 | 37,913 | 5,625 | |
May 27 2010 | INFI | INFINITY PHARMACEU ... | Tucker Winselow S. Jr. | Vice President, Mar ... | Option Exercise | A | 6.74 | 75,000 | 505,500 | 75,000 | |
Jan 07 2010 | INFI | INFINITY PHARMACEU ... | Tong Jeffrey K | VP, Cor. & Product ... | Option Exercise | A | 6.25 | 15,440 | 96,500 | 15,440 | |
Jan 07 2010 | INFI | INFINITY PHARMACEU ... | Quirk Gerald E | VP,Cor. Affairs & G ... | Option Exercise | A | 6.25 | 25,440 | 159,000 | 25,440 | |
Jan 07 2010 | INFI | INFINITY PHARMACEU ... | Perkins Adelene Q | Pres & Chief Execut ... | Option Exercise | A | 6.25 | 364,000 | 2,275,000 | 364,000 | |
Jan 07 2010 | INFI | INFINITY PHARMACEU ... | ADAMS JULIAN | President of R&D an ... | Option Exercise | A | 6.25 | 104,000 | 650,000 | 104,000 | |
Jan 07 2010 | INFI | INFINITY PHARMACEU ... | Lindblom Christopher M | Controller & Asst. ... | Option Exercise | A | 6.25 | 9,238 | 57,738 | 9,238 | |
Jan 07 2010 | INFI | INFINITY PHARMACEU ... | Holtzman Steven H | Director | Option Exercise | A | 6.25 | 156,000 | 975,000 | 156,000 | |
Oct 08 2009 | INFI | INFINITY PHARMACEU ... | Lynch Thomas J. Jr. | Director | Option Exercise | A | 6.24 | 9,375 | 58,500 | 9,375 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 5.63 | 9,375 | 52,781 | 9,375 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | EVNIN ANTHONY B | Director | Option Exercise | A | 5.63 | 5,625 | 31,669 | 5,625 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | LANDER ERIC S | Director | Option Exercise | A | 5.63 | 5,625 | 31,669 | 5,625 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 5.63 | 3,750 | 21,113 | 3,750 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | VENUTI MICHAEL C | Director | Option Exercise | A | 5.63 | 5,625 | 31,669 | 5,625 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 5.63 | 3,750 | 21,113 | 3,750 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | SMITH IAN F | Director | Option Exercise | A | 5.63 | 5,625 | 31,669 | 5,625 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | TANANBAUM JAMES B | Director | Option Exercise | A | 5.63 | 5,625 | 31,669 | 5,625 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | Babler Martin | Director | Option Exercise | A | 5.63 | 1,875 | 10,556 | 1,875 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | Babler Martin | Director | Option Exercise | A | 5.63 | 5,625 | 31,669 | 5,625 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | Moss Franklin | Director | Option Exercise | A | 5.63 | 5,625 | 31,669 | 5,625 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | LEVINE ARNOLD J | Director | Option Exercise | A | 5.63 | 5,625 | 31,669 | 5,625 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | Lee Patrick Pak-Tin | Director | Option Exercise | A | 5.63 | 5,625 | 31,669 | 5,625 | |
Jun 19 2009 | INFI | INFINITY PHARMACEU ... | HIXSON HARRY F JR | Director | Option Exercise | A | 5.63 | 5,625 | 31,669 | 5,625 |